Research consultancy services

Description

In order to successfully deliver the ATIMP clinical trials that we run, support from a variety of ancillary services (including biometrics, Pharmacovigilance, central labs etc.) is essential. Cell & Gene Therapy therefore by way of this procurement exercise are seeking to appoint a framework agreement comprising of the following 6 lots: Lot 1 Biometrics Phase 1 & 2 — small to medium size ATIMP. Lot 2 Central Laboratory Requirements. Lot 3 Clinical Services. Lot 4 Pharma-covigilance. Lot 5 Translation Services. Lot 6 Bespoke Service Providers. Please note Lot 6 is for only appointed suppliers who cannot fulfil the whole requirements of Lot 1-5 but are able to offer some bespoke elements of the relevant lot(s) specification requirements. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months.